Exact Mass: 311.127

Exact Mass Matches: 311.127

Found 17 metabolites which its exact mass value is equals to given mass value 311.127, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

IMAZAQUIN

IMAZAQUIN

C17H17N3O3 (311.127)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7950; ORIGINAL_PRECURSOR_SCAN_NO 7948 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7948; ORIGINAL_PRECURSOR_SCAN_NO 7947 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3770; ORIGINAL_PRECURSOR_SCAN_NO 3769 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3779; ORIGINAL_PRECURSOR_SCAN_NO 3778 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3762; ORIGINAL_PRECURSOR_SCAN_NO 3761 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7947; ORIGINAL_PRECURSOR_SCAN_NO 7945 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3761; ORIGINAL_PRECURSOR_SCAN_NO 3760 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7928; ORIGINAL_PRECURSOR_SCAN_NO 7927 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7919; ORIGINAL_PRECURSOR_SCAN_NO 7918 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7962; ORIGINAL_PRECURSOR_SCAN_NO 7957 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3745; ORIGINAL_PRECURSOR_SCAN_NO 3744 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3711

   

1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one

1-(4-Aminophenyl)--3,5-dihydro-7,8-dimethoxy-4H-2,3-benzodiazepin-4-one

C17H17N3O3 (311.127)


CFM-2 is a potent and selective non-competitive AMPAR antagonist[1]. CFM-2 possesses anticonvulsant activity in various models of seizures[2].

   

Dehydroisolongistrobine

Dehydroisolongistrobine

C17H17N3O3 (311.127)


   

Dehydro-isolongistrobin|Dehydroisolongistrobin

Dehydro-isolongistrobin|Dehydroisolongistrobin

C17H17N3O3 (311.127)


   

methyl 1-((2-methyl carbamate)ethyl)-beta-carboline-3-carboxylate

methyl 1-((2-methyl carbamate)ethyl)-beta-carboline-3-carboxylate

C17H17N3O3 (311.127)


   

N-(4-METHOXYPHENYL)-2-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-2-YL)ACETAMIDE

N-(4-METHOXYPHENYL)-2-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-2-YL)ACETAMIDE

C17H17N3O3 (311.127)


   

1-ISOPENTYL-7-PHENYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

1-ISOPENTYL-7-PHENYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

C17H17N3O3 (311.127)


   

(R)-Imazaquin

(R)-Imazaquin

C17H17N3O3 (311.127)


   

4-[5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl]pyridine

4-[5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl]pyridine

C17H17N3O3 (311.127)


   

(S)-Imazaquin

(S)-Imazaquin

C17H17N3O3 (311.127)


   

N-{2-[(4-Cyano-1,1-biphenyl-4-YL)oxy]ethyl}-N-hydroxy-N-methylurea

N-{2-[(4-Cyano-1,1-biphenyl-4-YL)oxy]ethyl}-N-hydroxy-N-methylurea

C17H17N3O3 (311.127)


   

5-(2-Ethoxyphenyl)-3-(2-methoxy-6-methyl-3-pyridinyl)-1,2,4-oxadiazole

5-(2-Ethoxyphenyl)-3-(2-methoxy-6-methyl-3-pyridinyl)-1,2,4-oxadiazole

C17H17N3O3 (311.127)


   

CFM 2

1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one

C17H17N3O3 (311.127)


CFM-2 is a potent and selective non-competitive AMPAR antagonist[1]. CFM-2 possesses anticonvulsant activity in various models of seizures[2].

   

4-{[2-(2,4-dimethoxyphenyl)-1,2,4-triazol-3-yl]methyl}phenol

4-{[2-(2,4-dimethoxyphenyl)-1,2,4-triazol-3-yl]methyl}phenol

C17H17N3O3 (311.127)


   

(6s)-2-hydroxy-6-[2-(3-methylimidazol-4-yl)-2-oxoethyl]-4,6-dihydro-3h-1-benzazocin-5-one

(6s)-2-hydroxy-6-[2-(3-methylimidazol-4-yl)-2-oxoethyl]-4,6-dihydro-3h-1-benzazocin-5-one

C17H17N3O3 (311.127)


   

2-hydroxy-6-[2-(3-methylimidazol-4-yl)-2-oxoethyl]-4,6-dihydro-3h-1-benzazocin-5-one

2-hydroxy-6-[2-(3-methylimidazol-4-yl)-2-oxoethyl]-4,6-dihydro-3h-1-benzazocin-5-one

C17H17N3O3 (311.127)


   

3-[3-(methoxycarbonyl)-9h-pyrido[3,4-b]indol-1-yl]-n-methylpropanimidic acid

3-[3-(methoxycarbonyl)-9h-pyrido[3,4-b]indol-1-yl]-n-methylpropanimidic acid

C17H17N3O3 (311.127)